Cuatrecasas advises Aleos Capital on majority stake in Eggnovo
Cuatrecasas has advised Aleos Capital, a Spanish private equity manager, on the acquisition of a majority stake in Eggnovo. This transaction represents Aleos Capital’s first investment through its fund and marks the start of its investment activity.
With more than a decade of experience and a circular economy approach embedded in the company’s DNA, Eggnovo produces natural ingredients extracted from eggshell membrane for the food, health and cosmetics sectors. From this membrane, the company develops ingredients that combine compounds such as collagen, hyaluronic acid and elastin, among others, particularly suited to supporting joint health, skin care and overall wellbeing.
The transaction will support Eggnovo’s growth, strengthen its international expansion and consolidate its positioning in the market for natural ingredients for nutraceutical, cosmetic, veterinary and food applications.
The Cuatrecasas team advising on the transaction included partner Francisco Martínez Maroto, and senior associate Pedro López-Dóriga, as well as Catalina Guzmán Guzmán, Leticia García-Gallardo Martínez, Rocío Quintanilla Arasa and Pablo Castillo Artacho, from the Corporate/M&A team.
In the picture, Francisco Martínez Maroto and Pedro López-Dóriga.